Literature DB >> 25680285

Nrf2-dependent repression of interleukin-12 expression in human dendritic cells exposed to inorganic arsenic.

Mélinda Macoch1, Claudie Morzadec1, Romain Génard2, Marc Pallardy2, Saadia Kerdine-Römer2, Olivier Fardel3, Laurent Vernhet4.   

Abstract

Inorganic arsenic, a well-known Nrf2 inducer, exerts immunosuppressive properties. In this context, we recently reported that the differentiation of human blood monocytes into immature dendritic cells (DCs), in the presence of low and noncytotoxic concentrations of arsenic, represses the ability of DCs to release key cytokines in response to different stimulating agents. Particularly, arsenic inhibits the expression of human interleukin-12 (IL-12, also named IL-12p70), a major proinflammatory cytokine that controls the differentiation of Th1 lymphocytes. In the present study, we determined if Nrf2 could contribute to these arsenic immunotoxic effects. To this goal, human monocyte-derived DCs were first differentiated in the absence of metalloid and then pretreated with arsenic just before DC stimulation with lipopolysaccharide (LPS). Under these experimental conditions, arsenic rapidly and stably activates Nrf2 and increases the expression of Nrf2 target genes. It also significantly inhibits IL-12 expression in activated DCs, at both mRNA and protein levels. Particularly, arsenic reduces mRNA levels of IL12A and IL12B genes which encodes the p35 and p40 subunits of IL-12p70, respectively. tert-Butylhydroquinone (tBHQ), a reference Nrf2 inducer, mimics arsenic effects and potently inhibits IL-12 expression. Genetic inhibition of Nrf2 expression markedly prevents the repression of both IL12 mRNA and IL-12 protein levels triggered by arsenic and tBHQ in human LPS-stimulated DCs. In addition, arsenic significantly reduces IL-12 mRNA levels in LPS-activated bone marrow-derived DCs from Nrf2+/+ mice but not in DCs from Nrf2-/- mice. Finally, we show that, besides IL-12, arsenic significantly reduces the expression of IL-23, another heterodimer containing the p40 subunit. In conclusion, our study demonstrated that arsenic represses IL-12 expression in human-activated DCs by specifically stimulating Nrf2 activity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dendritic cells; Inorganic arsenic; Interleukin-12; Nrf2

Mesh:

Substances:

Year:  2015        PMID: 25680285     DOI: 10.1016/j.freeradbiomed.2015.02.003

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  10 in total

1.  Nrf2 regulates PU.1 expression and activity in the alveolar macrophage.

Authors:  Bashar S Staitieh; Xian Fan; Wendy Neveu; David M Guidot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-03       Impact factor: 5.464

2.  Protection of Nrf2 against arsenite-induced oxidative damage is regulated by the cyclic guanosine monophosphate-protein kinase G signaling pathway.

Authors:  Chengzhi Chen; Xuejun Jiang; Shiyan Gu; Yanhao Lai; Yuan Liu; Zunzhen Zhang
Journal:  Environ Toxicol       Date:  2016-10-24       Impact factor: 4.119

3.  Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice.

Authors:  Takuma Suzuki; Shohei Murakami; Shyam S Biswal; Shimon Sakaguchi; Hideo Harigae; Masayuki Yamamoto; Hozumi Motohashi
Journal:  Mol Cell Biol       Date:  2017-07-14       Impact factor: 4.272

Review 4.  Old dog, new trick: Trivalent arsenic as an immunomodulatory drug.

Authors:  Yishan Ye; Béatrice Gaugler; Mohamad Mohty; Florent Malard
Journal:  Br J Pharmacol       Date:  2020-03-12       Impact factor: 8.739

5.  The Nrf2 activator tBHQ inhibits the activation of primary murine natural killer cells.

Authors:  Allison P Boss; Robert A Freeborn; David M Duriancik; Rebekah C Kennedy; Elizabeth M Gardner; Cheryl E Rockwell
Journal:  Food Chem Toxicol       Date:  2018-08-30       Impact factor: 6.023

6.  Inhibition of the inflammatory response to stress by targeting interaction between PKR and its cellular activator PACT.

Authors:  Stephanie Dabo; Patrick Maillard; Milagros Collados Rodriguez; Marianne Doré Hansen; Sabrina Mazouz; Donna-Joe Bigot; Marion Tible; Geneviève Janvier; Olivier Helynck; Patricia Cassonnet; Yves Jacob; Jacques Bellalou; Anne Gatignol; Rekha C Patel; Jacques Hugon; Hélène Munier-Lehmann; Eliane F Meurs
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

7.  Genome-wide alteration of histone methylation profiles associated with cognitive changes in response to developmental arsenic exposure in mice.

Authors:  Nicholas F Fitz; Aaron Barchowsky; Radosveta Koldamova; Iliya Lefterov
Journal:  Toxicol Rep       Date:  2022-03-04

Review 8.  Redox regulation of the immune response.

Authors:  Gerwyn Morris; Maria Gevezova; Victoria Sarafian; Michael Maes
Journal:  Cell Mol Immunol       Date:  2022-09-02       Impact factor: 22.096

9.  Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity.

Authors:  Yuhei Nishimura; Shota Sasagawa; Michiko Ariyoshi; Sayuri Ichikawa; Yasuhito Shimada; Koki Kawaguchi; Reiko Kawase; Reiko Yamamoto; Takuma Uehara; Takaaki Yanai; Ryoji Takata; Toshio Tanaka
Journal:  Front Pharmacol       Date:  2015-09-15       Impact factor: 5.810

10.  Investigating Molecular Mechanisms of Immunotoxicity and the Utility of ToxCast for Immunotoxicity Screening of Chemicals Added to Food.

Authors:  Olga V Naidenko; David Q Andrews; Alexis M Temkin; Tasha Stoiber; Uloma Igara Uche; Sydney Evans; Sean Perrone-Gray
Journal:  Int J Environ Res Public Health       Date:  2021-03-24       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.